Hyperphosphatemia

Phosphate Enemas Can Cause Hyperphosphatemia

Phosphate Enemas Can Cause Hyperphosphatemia

By

Purgative products introduce 10 times the normal daily amount of phosphorus into the body.

Dialysis Patient Age May Affect Hyperphosphatemia Management

Dialysis Patient Age May Affect Hyperphosphatemia Management

By

Younger patients are less likely to respond to treatment with sucroferric oxyhydroxide or sevelamer.

Prescribed Meds May Up Phosphate Burden in Hemodialysis Patients

Prescribed Meds May Up Phosphate Burden in Hemodialysis Patients

By

Study implicates amlodipine, lisinopril, clonidine, acetaminophen, and omeprazole.

Phosphate Binder Switch Found to Benefit Peritoneal Dialysis Patients

Phosphate Binder Switch Found to Benefit Peritoneal Dialysis Patients

By

The percentage of patients with serum phosphorus levels of 5.5 mg/dL and below more than doubled to 37.8% after 6 months of treatment with sucroferric oxyhydroxide.

Sucroferric Oxyhydroxide Helps More Hyperphosphatemia Pts Reach Target

Sucroferric Oxyhydroxide Helps More Hyperphosphatemia Pts Reach Target

By

Patients also needed fewer phosphate binder pills over time.

ESRD Linked to Diet Soda Consumption

ESRD Linked to Diet Soda Consumption

By

The risk of end-stage renal disease was 83% higher for those who drank more than 7 glasses of diet soft drinks weekly.

Intensive Hemodialysis Effective for Treating Hyperphosphatemia

Intensive Hemodialysis Effective for Treating Hyperphosphatemia

By

It can sharply lower serum phosphorus levels and reduce dependence on phosphate binders.

Cutting Phosphorus Additives Reduces Hyperphosphatemia

Cutting Phosphorus Additives Reduces Hyperphosphatemia

By

In a study, 69.7% of intervention patients attained serum phosphorus levels below 5.5 mg/dL, compared with just 18.5% of control patients.

Dietary Management May Aid Transition to Incremental HD

Dietary Management May Aid Transition to Incremental HD

By

A low protein, low phosphorus diet plays an important role in the nutritional management of patients transitioning to once-weekly incremental hemodialysis.

Hyperphosphatemia Linked With Mortality in Septic AKI

Hyperphosphatemia Linked With Mortality in Septic AKI

By

Hyperphosphatemia was associated with more than double the risk of death from any cause.

Teaching Low Phosphorus Cooking May Improve Hyperphosphatemia

Teaching Low Phosphorus Cooking May Improve Hyperphosphatemia

By

Patients reduced dietary phosphorus without compromising protein intake.

Nutritional Databases Underreport Phosphorus Content

Nutritional Databases Underreport Phosphorus Content

By

The USDA Standard Nutrient Reference Database, for example, listed phosphorus amounts for just 5 of 46 beverages.

Serum Phosphorus Linked With Left Ventricular Remodeling

Serum Phosphorus Linked With Left Ventricular Remodeling

By

For each 1 mmol/L increase in serum phosphorus, the odds of left ventricular hypertrophy more than doubled.

Study: Phosphate Binders Do Not Lower Death Risk

Study: Phosphate Binders Do Not Lower Death Risk

By

Calcium-based binders, however, are associated with greater odds of all-cause mortality versus sevelamer.

Uncontrolled Phosphorus Linked to Poor Binder Adherence

Uncontrolled Phosphorus Linked to Poor Binder Adherence

By

In a study, 61% of hemodialysis patients reported accidentally forgetting to take their medication or otherwise skipping doses unintentionally.

Natural Vitamin D Supplement Effective for Nondialysis CKD-MBD

Natural Vitamin D Supplement Effective for Nondialysis CKD-MBD

By

Over 33 months, the 25-hydroxyvitamin D level of ergocalciferol recipients increased significantly from 15.14 to 37.32 ng/mL.

Low-Dose Niacin Helps Lower Phosphorus Levels

Low-Dose Niacin Helps Lower Phosphorus Levels

By

Researchers evaluated the efficacy of 100 mg/day of niacin in hemodialysis patients.

Sucroferric Oxyhydroxide Exhibits a Dose-Dependent Effect

Sucroferric Oxyhydroxide Exhibits a Dose-Dependent Effect

By

The phosphate binder is a useful treatment for hyperphosphatemia with a relatively low pill burden, researchers say.

Study: Minimal Risk of Iron Overload With Sucroferric Oxyhydroxide

Study: Minimal Risk of Iron Overload With Sucroferric Oxyhydroxide

By

Patients may need no more than routine evaluation of iron.

Even High-Normal Phosphorus May Be an ESRD Risk Factor, Study Finds

Even High-Normal Phosphorus May Be an ESRD Risk Factor, Study Finds

By

Phosphorus targets in patients with chronic kidney disease stage 3 to 4 should be below 4.3 mg/dL, researchers report.

Young Patients Often Misperceive Adherence to Phosphorus Control

Young Patients Often Misperceive Adherence to Phosphorus Control

By

Hyperphosphatemia is present in many who say following diets and binder schedules is easy.

Patient Autonomy May Improve Phosphate Binder Adherence

Patient Autonomy May Improve Phosphate Binder Adherence

By

Autonomy support could be an appropriate target for culturally informed strategies to optimize mineral bone health.

Calcium-based Phosphate Binders Linked to Higher Mortality

Calcium-based Phosphate Binders Linked to Higher Mortality

By

A mortality rate increase of 43 cases per 1000 patients was found for calcium-based phosphate binders.

When Blood Is Sampled Affects Dialysis Patients' Phosphorus Values

When Blood Is Sampled Affects Dialysis Patients' Phosphorus Values

By

Phosphorus levels are higher when blood specimens are collected after weekends.

Proposed Regimen May Cut Hypercalcemia Risk in CKD Patients

Proposed Regimen May Cut Hypercalcemia Risk in CKD Patients

By

Paricalcitol-based protocol includes limited use of calcium-based phosphate binders.

Why SHPT Remains Difficult to Treat

Why SHPT Remains Difficult to Treat

By

The control of phosphorus is underappreciated, for example.

Niacin's Phosphorus-Lowering Effect Confirmed

Niacin's Phosphorus-Lowering Effect Confirmed

By

Average 6-month serum phosphorus level was significantly lower in CKD patients who received niacin than those who did not (3.4 vs. 4.2 mg/dL).

Iron-Based Binder Found to Improve Phosphorus Control, Cut Pill Burden

Iron-Based Binder Found to Improve Phosphorus Control, Cut Pill Burden

By

Researchers observe an 81% increase in dialysis patients achieving recommended phosphorus levels after switching to sucroferric oxyhydroxide.

Multimodal Therapy for Calciphylaxis Shows Favorable Results

Multimodal Therapy for Calciphylaxis Shows Favorable Results

By

Small case series also confirmed that the diagnosis of calciphylaxis is rarely made in the nodular, non-ulcerative phase.

Fixed-Dose Phosphate Binder Schedules May Be Less Than Ideal

Fixed-Dose Phosphate Binder Schedules May Be Less Than Ideal

By

Study of peritoneal dialysis patients showed that they do not adjust binders to match the phosphate content of meals and snacks.

Sign Up for Free e-newsletters